Loading clinical trials...
Loading clinical trials...
A Prospective, Single-arm, Single-center Clinical Trial of Envafolimab as First-line Replacement Maintenance in Advanced NSCLC
Conditions
Interventions
Envafolimab;Pemetrexed
Locations
1
China
The First Affiliated Hospital of Xian Jiaotong University
Xi’an, Shanxi, China
Start Date
August 1, 2022
Primary Completion Date
June 30, 2025
Completion Date
June 30, 2025
Last Updated
July 20, 2022
NCT06855771
NCT06758401
NCT04895709
NCT06120140
NCT06487078
NCT07336732
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions